Abstract:BACKGROUND & AIMS Inflammatory bowel disease (IBD) is a complex and relapsing inflammatory disease, and patients with IBD exhibit a higher risk of developing colorectal cancer (CRC). Epithelial barrier disruption is one of the major causes of IBD in which epigenetic modulation is pivotal. However, the epigenetic mechanisms underlying the epithelial barrier integrity regulation remain largely unexplored. Here, we investigated how SETD2, an epigenetic modifier, maintains intestinal epithelial homeostasis and attenuates colonic inﬂammation and tumorigenesis. METHODS GEO public database and IBD tissues were used to investigate the clinical relevance of SETD2 in IBD. To define a role of SETD2 in the colitis, we generated mice with epithelium-specific deletion of Setd2 ( Setd2 Vil-KO mice). Acute colitis was induced by 2% dextran sodium sulfate (DSS), and colitis-associated CRC was induced by injecting azoxymethane (AOM), followed by three cycles of 2% DSS treatments. Colon tissues were collected from mice and analyzed by histology, immunohistochemistry and immunoblots. Organoids were generated from Setd2Vil-KO and control mice, and were stained with 7-AAD to detect apoptosis. A fluorescent probe, 2′,7′-dichlorodihydroﬂuorescein diacetate (H2DCFDA), was used to detect the levels of ROS in intestinal epithelial cells (IECs) isolated from the two types of mice. RNA-seq and H3K36me3 ChIP-seq analyses were performed to identify the mis-regulated genes modulated by SETD2. Results were validated in functional rescue experiments by N-acetyl-l-cysteine (NAC) treatment and transgenes expression in IECs. RESULTS SETD2 expression became decreased in IBD patients and DSS-treated colitis mice. Setd2 Vil-KO mice displayed abnormal loss of mucus-producing goblet cells and antimicrobial peptide (AMP)-producing Paneth cells, and exhibited pre-mature intestinal inflammation development. Consistent with the reduced SETD2 expression in IBD patients, Setd2 Vil-KO mice showed increased susceptibility to DSS-induced colitis, accompanied by more severe epithelial barrier disruption and markedly increased intestinal permeability that subsequently facilitated inﬂammation-associated CRC. Mechanistically, deletion of Setd2 resulted in excess reactive oxygen species (ROS), which led to cellular apoptosis and defects in barrier integrity. NAC treatment in Setd2 Vil-KO mice rescued epithelial barrier injury and apoptosis. Importantly, Setd2 depletion led to excess ROS by directly down-regulating antioxidant genes that inhibit ROS reaction. Moreover, overexpression of antioxidant PRDX6 in Setd2 Vil-KO IECs largely alleviated the overproductions of ROS and improved the cellular survival. CONCLUSIONS Deficiency of Setd2 specifically in the intestine aggravates epithelial barrier disruption and inflammatory response in colitis via a mechanism dependent on oxidative stress. Thus, our results highlight an epigenetic mechanism by which Setd2 modulates oxidative stress to regulate intestinal epithelial homeostasis. SETD2 might therefore be a pivotal regulator that maintains the homeostasis of the intestinal mucosal barrier. ### Competing Interest Statement The authors have declared no competing interest. * AMP : antimicrobial peptide AOM : azoxymethane 7-AAD : 7- aminoactinomycin D CD : Crohn’s disease CRC : colorectal cancer DSS : dextran sodium sulfate GO : gene ontology H2DCFDA : 2′,7′-dichlorodihydroﬂuorescein diacetate H3K36 : histone H3 lysine 36 IBD : inflammatory bowel disease IEC : intestinal epithelial cell NAC : N-acetyl-l-cysteine 8-OHdG : 8-oxo-2’- deoxyguanosine PRDX : peroxiredoxin ROS : reactive oxygen species RT-qPCR : Real-Time quantitative PCR UC : ulcerative colitis ZO-1 : tight junction protein 1.

Sulfamethoxazole drug stress upregulates antioxidant immunomodulatory metabolites in Escherichia coli

P149 Bacteroides uniformis ameliorates pro-inflammatory diet-exacerbated colitis by targeting endoplasmic reticulum stress-mediated ferroptosis

Gut bacterial metabolites modulate endoplasmic reticulum stress

Patient-derived Enterococcus faecium with inflammatory genotypes promote colitis

Tripartite motif containing 59 mediates protective anti-oxidative effects in intestinal injury through Nrf2 signaling

High-Fat Diets Cause A Shift from Anti-Inflammatory Iga to Pro-Inflammatory Igg Responses Against Commensal Gut Bacteria: A Novel Mechanism for Diet-Induced Metabolic Inflammation

Synthesis and antibacterial activity of FST and its effects on inflammatory response and intestinal barrier function in mice infected with Escherichia coli O78

The Histone Methyltransferase SETD2 Modulates Oxidative Stress to Attenuate Colonic Inflammation and Tumorigenesis in Mice

P060 Unravelling the microbial-derived metabolic alterations in a T-bet-/- x RAG2-/- mouse colitis model

Lipopolysaccharide O structure of adherent and invasive Escherichia coli regulates intestinal inflammation via complement C3

Network Analysis of Gut Microbial Communities Reveals Key Reason for Quercetin Protects against Colitis

Colonic Dysregulation of Major Metabolic Pathways in Experimental Ulcerative Colitis

A novel stress-inducible CmtR-ESX3-Zn2+ regulatory pathway essential for survival of Mycobacterium bovis under oxidative stress

Metabolites of stable fly reduce diarrhea in mice by modulating the immune system, antioxidants, and composition of gut microbiota

Limitation of amino acid availability by bacterial populations during enhanced colitis in IBD mouse model

Akkermansia muciniphila and its outer protein Amuc_1100 regulates tryptophan metabolism in colitis

Colonic epithelial cell-specific TFEB activation: a key mechanism promoting anti-bacterial defense in response to Salmonella infection

Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin

Salmonella proteomics under oxidative stress reveals coordinated regulation of antioxidant defense with iron metabolism and bacterial virulence.

The emerging role of oxidative stress in inflammatory bowel disease

Mitigation of Dextran-Sodium-Sulfate-Induced Colitis in Mice through Oral Administration of Microbiome-Derived Inosine and Its Underlying Mechanisms